U.S. FDA Approves Serenity Pharmaceutical’s Noctiva(TM) (desmopressin acetate) – the First Drug Approved for the Treatment of Nocturia

MILFORD, Pa.--(Healthcare Sales & Marketing Network)--Serenity Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved Noctiva™ (desmopressin acetate) nasal spray for the treatment of nocturia due to nocturnal polyuria in adults... Biopharmaceuticals, FDA Serenity Pharmaceuticals, Noctiva, desmopressin, nocturia

Source: HSMN NewsFeed - March 7, 2017 Category: Pharmaceuticals Source Type: news